Dysphagia Supplements Market size was valued at USD 1032.1 million in 2021 and is expected to reach USD 1504.6 million by 2028, at a CAGR of 5.6% during the forecast period 2022 to 2028. Dysphagia is referred as symptoms of difficulty & pain in swallowing. Furthermore in some of the cases swallowing may be impossible. Difficulty in swallowing may occur in fast eating and food is not chewed properly. But persistent dysphagia is a serious condition which needs treatment. Dysphagia occurs at any age but more common in older adults. Other symptoms may include drooling, regurgitations, frequent heartburn and others. There are two types of dysphagia, esophageal and oropharyngeal and many of the causes such as radiation therapy, scleroderma, neuronal disorders and esophageal tumors and other many causes lead to dysphagia. Dysphagia Supplements market is expected to grow at significant rates owing to the factors such as esophageal cancer and growing aging population. According to World Health Organization (WHO), in 2010, estimated 524 million people are aged over 65 and it is expected to triple its number 1.5 billion in 2050. The marketplace has many strong players and scattered globally. Companies are collaborating the hospitals and nursing homes in dysphagia supplements market. Furthermore, new product development and mergers and acquisitions key strategies adopted by the companies in the regions for expanding their global presence.
Key Developments Of Dysphagia Supplements Market :
In April 2017, Nestle Health Science and Chinese Stroke Association entered into a collaboration agreement to help the stroke patients to swallow with less difficulty. With this collaboration, companies seek to explore ways to improve screening, diagnosis, and management of dysphagia among stroke patients.
In 2016, Alicia Foundation collaborated with Nutricia for suppling Catalonian hospitals with Nutilis thickening product from the company.